Cargando…

Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study

BACKGROUND: It has been postulated that Multiple sclerosis (MS) stems from a narrowing in the veins that drain blood from the brain, known medically as chronic cerebrospinal venous insufficiency, or CCSVI. It has been proposed that balloon angioplasty should alleviate the symptoms of MS. This proced...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Saurabh, Bhatia, Anshul, Rajkumar, Sapra, Harsh, Gupta, Vipul, Mehta, Yatin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591554/
https://www.ncbi.nlm.nih.gov/pubmed/23493652
http://dx.doi.org/10.4103/1658-354X.105865
_version_ 1782262070761226240
author Anand, Saurabh
Bhatia, Anshul
Rajkumar,
Sapra, Harsh
Gupta, Vipul
Mehta, Yatin
author_facet Anand, Saurabh
Bhatia, Anshul
Rajkumar,
Sapra, Harsh
Gupta, Vipul
Mehta, Yatin
author_sort Anand, Saurabh
collection PubMed
description BACKGROUND: It has been postulated that Multiple sclerosis (MS) stems from a narrowing in the veins that drain blood from the brain, known medically as chronic cerebrospinal venous insufficiency, or CCSVI. It has been proposed that balloon angioplasty should alleviate the symptoms of MS. This procedure is also known as The “Liberation Procedure”. Accordingly, a clinical study was undertaken to determine the effects of dexmedetomidine in patients undergoing the liberation procedure. AIMS: To assess the effectiveness of dexmedetomidine in providing adequate sedation and pain relief for patients undergoing the liberation procedure. SETTINGS AND DESIGN: A prospective, nonrandomized observational study of 60 consecutive adult patients undergoing the liberation procedure under monitored anesthesia care (MAC) who will receive dexmedetomidine as an anesthetic agent. METHODS: A total of 60 adult patients were enrolled in the study. Dexmedetomidine was administered to all patients in a loading dose of 1 mcg/kg, which was followed by a maintenance dose of 0.2–0.5 mcg/kg/h. The evaluation of quality of sedation was based on Ramsay Sedation and the quality of analgesia was assessed using the visual analog scale. The following parameters were measured continuously: heart rate, mean arterial pressure and hemoglobin oxygen saturation. Patients were asked to answer the question, “How would you rate your experience with the sedation you have received during surgery?” using a seven-point Likert-like verbal rating scale. STATISTICAL ANALYSIS: Repeated measurements were analyzed by repeated measures ANOVA for HR and BP. RESULTS: Most of our patients were satisfied with their sedation. In most of the patients, MAP and HR dropped after the bolus dose of dexmedetomidine, and the drop was statistically significant. CONCLUSIONS: Dexmedetomidine can be used as a sole sedative agent in patients undergoing the liberation procedure.
format Online
Article
Text
id pubmed-3591554
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-35915542013-03-14 Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study Anand, Saurabh Bhatia, Anshul Rajkumar, Sapra, Harsh Gupta, Vipul Mehta, Yatin Saudi J Anaesth Original Article BACKGROUND: It has been postulated that Multiple sclerosis (MS) stems from a narrowing in the veins that drain blood from the brain, known medically as chronic cerebrospinal venous insufficiency, or CCSVI. It has been proposed that balloon angioplasty should alleviate the symptoms of MS. This procedure is also known as The “Liberation Procedure”. Accordingly, a clinical study was undertaken to determine the effects of dexmedetomidine in patients undergoing the liberation procedure. AIMS: To assess the effectiveness of dexmedetomidine in providing adequate sedation and pain relief for patients undergoing the liberation procedure. SETTINGS AND DESIGN: A prospective, nonrandomized observational study of 60 consecutive adult patients undergoing the liberation procedure under monitored anesthesia care (MAC) who will receive dexmedetomidine as an anesthetic agent. METHODS: A total of 60 adult patients were enrolled in the study. Dexmedetomidine was administered to all patients in a loading dose of 1 mcg/kg, which was followed by a maintenance dose of 0.2–0.5 mcg/kg/h. The evaluation of quality of sedation was based on Ramsay Sedation and the quality of analgesia was assessed using the visual analog scale. The following parameters were measured continuously: heart rate, mean arterial pressure and hemoglobin oxygen saturation. Patients were asked to answer the question, “How would you rate your experience with the sedation you have received during surgery?” using a seven-point Likert-like verbal rating scale. STATISTICAL ANALYSIS: Repeated measurements were analyzed by repeated measures ANOVA for HR and BP. RESULTS: Most of our patients were satisfied with their sedation. In most of the patients, MAP and HR dropped after the bolus dose of dexmedetomidine, and the drop was statistically significant. CONCLUSIONS: Dexmedetomidine can be used as a sole sedative agent in patients undergoing the liberation procedure. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3591554/ /pubmed/23493652 http://dx.doi.org/10.4103/1658-354X.105865 Text en Copyright: © Saudi Journal of Anaesthesia http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Anand, Saurabh
Bhatia, Anshul
Rajkumar,
Sapra, Harsh
Gupta, Vipul
Mehta, Yatin
Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study
title Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study
title_full Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study
title_fullStr Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study
title_full_unstemmed Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study
title_short Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study
title_sort dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: an observational study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591554/
https://www.ncbi.nlm.nih.gov/pubmed/23493652
http://dx.doi.org/10.4103/1658-354X.105865
work_keys_str_mv AT anandsaurabh dexmedetomidineformonitoredanesthesiacareinpatientsundergoingliberationprocedureformultiplesclerosisanobservationalstudy
AT bhatiaanshul dexmedetomidineformonitoredanesthesiacareinpatientsundergoingliberationprocedureformultiplesclerosisanobservationalstudy
AT rajkumar dexmedetomidineformonitoredanesthesiacareinpatientsundergoingliberationprocedureformultiplesclerosisanobservationalstudy
AT sapraharsh dexmedetomidineformonitoredanesthesiacareinpatientsundergoingliberationprocedureformultiplesclerosisanobservationalstudy
AT guptavipul dexmedetomidineformonitoredanesthesiacareinpatientsundergoingliberationprocedureformultiplesclerosisanobservationalstudy
AT mehtayatin dexmedetomidineformonitoredanesthesiacareinpatientsundergoingliberationprocedureformultiplesclerosisanobservationalstudy